Clinical Research/R&D

  • Your Selections:

Refine Results

date

Tags

Aflatoxin Treatment Project In Kenya Faces Challenge In Marketing Product To Poor Farmers

IRIN examines an 18-month project in Kenya testing a maize treatment aimed at controlling “a deadly fungus, aflatoxin,” which has the potential to cause cancer, immune system suppression, growth retardation, liver disease and death among the “literally billions of people in the developing world” who are chronically exposed to the fungus.

Multinational Drug Companies’ Scam

In an Al Jazeera opinion piece, the first in a two-part series, Khadija Sharife, a journalist and visiting scholar at the Center for Civil Society, examines how multinational drug companies control markets.

CSIS Report On Army And Navy Overseas Medical Research

This report, titled “The Future of the U.S. Army and Navy Overseas Medical Research,” from the Center for Strategic & International Studies lays out the research, conclusions, and recommendations from “a year-long, independent examination of the U.S. Army and Navy overseas medical research laboratories,” which “stand at the intersection of…

Drug Companies Collaborate With DNDi Support To Develop Drug For African Sleeping Sickness

Researchers from Scynexis Inc. of Research Triangle Park, N.C., and Anacor Pharmaceuticals in Palo Alto, Calif., sponsored by the Drugs for Neglected Diseases initiative, on Tuesday reported in the journal PLoS Neglected Tropical Diseases that a new experimental drug kills the parasite that causes African sleeping sickness in mice and will enter human clinical trials this year, ScienceNOW reports (Leslie, 6/28).

Global Malaria R&D Funding Has Received Sustained Growth, Report Says

“Annual funding for research and development (R&D) in the fight against malaria has quadrupled over 16 years, generating the strongest pipeline of potential treatments in history, according to a report [.pdf] on Tuesday,” Reuters reports (Kelland, 6/28).

Find A Better Way To Incorporate Evidence Into Health Policy

“Research evidence has undoubtedly been crucial in formulating countless global health policies which have saved many millions of lives,” but “at the same time, we believe there are several common fallacies about its ‘real world’ application,” Gavin Yamey and Richard Feachem of the Evidence to Policy initiative write in an Evidence-Based Medicine perspective.

Groups Join Forces To Research New Diarrheal Therapies

The Center for World Health and Medicine, the University of Missouri-St. Louis Medicinal Chemistry Group, and the Institute for One World Health have joined forces “to develop safe and effective anti-diarrhea drugs … aimed at preventing the massive water and electrolyte secretion that occurs in severe diarrhea,” which causes dehydration and electrolyte imbalance, the primary causes of death from diarrheal diseases, the St. Louis Beacon reports.

Nature News Examines Controversy Surrounding Indian HPV Vaccine Trial

After four teenage girls involved in a clinical trial in India testing vaccines for human papillomavirus (HPV) died last year, the study “threatens to have a dual legacy: inflaming unfounded fears about a lifesaving vaccine and raising new questions about the management of medical research in the country,” Nature News reports.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.